» Articles » PMID: 35097149

Effect of Naloxegol on Opioid-Induced Esophageal Motility Disorder

Overview
Journal ACG Case Rep J
Specialty Gastroenterology
Date 2022 Jan 31
PMID 35097149
Authors
Affiliations
Soon will be listed here.
Abstract

Opioid effects on lower gastrointestinal motility are well documented, and increasing attention is being paid to their effect on esophageal motility. Naloxegol is a µ-opioid receptor antagonist that is used for opioid-induced constipation, but its impact on esophageal motility has not been well documented. We report a case series of 3 patients with coexisting esophageal dysmotility and constipation on chronic opioids that improved both symptoms after starting naloxegol. Based on these observational studies, we propose that formal studies be conducted to assess the effect of naloxegol on opioid-induced esophageal dysmotility.

References
1.
Snyder D, Crowell M, Horsley-Silva J, Ravi K, Lacy B, Vela M . Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose. Am J Gastroenterol. 2019; 114(9):1464-1469. DOI: 10.14309/ajg.0000000000000369. View

2.
Ravi K, Murray J, Geno D, Katzka D . Achalasia and chronic opiate use: innocent bystanders or associated conditions?. Dis Esophagus. 2015; 29(1):15-21. DOI: 10.1111/dote.12291. View

3.
Lacy B . Effects of Opioids on Esophageal Dysfunction. Gastroenterol Hepatol (N Y). 2016; 12(5):323-5. PMC: 4973563. View

4.
Snyder D, Vela M . Opioid-induced esophageal dysfunction. Curr Opin Gastroenterol. 2020; 36(4):344-350. DOI: 10.1097/MOG.0000000000000648. View

5.
Chey W, Webster L, Sostek M, Lappalainen J, Barker P, Tack J . Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med. 2014; 370(25):2387-96. DOI: 10.1056/NEJMoa1310246. View